Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events "GENHART"


Phase N/A Results

Summary of Purpose

Renin-angiotensin-aldosterone system (RAAS) polymorphisms influence 24h arterial pressure fluctuation. Resistant systemic arterial hypertension (RSAH) has an increased risk of end organ damage and unfavourable prognosis, whereas pseudo-RSAH usually respond favourably to drug therapy. To prospectively investigate, in subjects with RSAH in a tropical South American city: 1) Adverse cardiovascular events...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 April 2013.

1 Jun 2001 29 Jul 2010 1 Nov 2009 1 Dec 2010 1 Apr 2013 21 Apr 2011
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample


Not available